Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Endocrinology · Geller Syndrome

The Biology of Geller Syndrome: Why the Body Retains Salt

At a Glance

Geller syndrome is a rare genetic cause of high blood pressure in which a kidney salt receptor stays active, causing salt and water retention and low potassium. In the classic form, pregnancy hormones can make blood pressure rise sharply.

To understand Geller syndrome, it helps to think of your kidneys as a complex filtration system that uses “sensors” to decide how much salt and water to keep in your blood. The most important sensor for salt balance is the mineralocorticoid receptor (MR) [1][2].

In a typical body, this receptor acts like a gatekeeper. It stays “closed” or inactive until a hormone called aldosterone binds to it. When aldosterone arrives, the receptor turns “on,” telling the kidneys to pull salt (sodium) back into the bloodstream. This process naturally raises blood pressure to healthy levels when needed [3][4].

The Mutation: An Inappropriate “On” Signal

Geller syndrome is caused by a specific genetic change, most classically the S810L mutation in the NR3C2 gene [1]. This is known as a gain-of-function variant because it makes the receptor overactive.

Instead of waiting for a signal from aldosterone, the mutated receptor is “leaky”—it is more easily activated [5][1]. This causes the kidneys to continuously reabsorb salt and water, leading to early-onset high blood pressure. At the same time, this overactivity forces the kidneys to flush out too much potassium, resulting in hypokalemia (low blood potassium) [1][4].

The Progesterone Paradox

The most striking biological feature of the classic S810L variant of Geller syndrome is how it reacts to progesterone, a hormone that increases significantly during pregnancy.

  • Normally: Progesterone is an antagonist to the mineralocorticoid receptor. This means it usually blocks the receptor, helping to keep blood pressure from getting too high during pregnancy [6][1].
  • In Geller Syndrome: Because of the S810L mutation, the receptor’s shape is slightly different. Instead of blocking the receptor, progesterone fits into it perfectly and acts as a powerful agonist (a trigger) [7][8].

When progesterone levels rise during pregnancy, they activate these mutated receptors, driving blood pressure dangerously high and causing potassium to drop rapidly [1][9]. This effect typically reverses shortly after the baby is born and progesterone levels fall [1][10].

Distinguishing Geller Syndrome from Similar Conditions

Because Geller syndrome causes high blood pressure and low potassium, it can be confused with other disorders. Doctors use blood tests to look at renin and aldosterone levels to tell them apart.

Condition Renin Level Aldosterone Level Key Biological Difference
Geller Syndrome Low (Suppressed) Low (Suppressed) Receptor is inappropriately active and can be triggered by progesterone [1].
Primary Aldosteronism Low High The body produces way too much aldosterone hormone [11].
Liddle Syndrome Low Low A different part of the kidney (the salt channel itself) is overactive [12].
Apparent Mineralocorticoid Excess (AME) Low Low The body can’t “deactivate” cortisol, so cortisol triggers the salt receptor instead [13].

A Note on Medications

The biology of the S810L mutation also changes how certain drugs work. For example, spironolactone is a common blood pressure medication that normally blocks the MR receptor. However, in people with the classic S810L mutation, spironolactone can actually activate the receptor, potentially making the condition worse [5]. Medication implications may depend on the exact variant you have, which is why an accurate genetic diagnosis and specialist interpretation are essential.

Common questions in this guide

What causes Geller syndrome?
Geller syndrome is caused by a gain-of-function change in the NR3C2 gene, most classically the S810L variant. This change makes the kidney’s mineralocorticoid receptor stay too active, so the body retains sodium and water and loses potassium even without a normal aldosterone signal.
Why can pregnancy make Geller syndrome worse?
Progesterone usually blocks the mineralocorticoid receptor, but the classic S810L variant changes the receptor so progesterone activates it instead. As progesterone rises during pregnancy, blood pressure may increase sharply and potassium may fall; these effects often improve after delivery as progesterone levels decrease.
What do low renin and low aldosterone mean in Geller syndrome?
Both renin and aldosterone are often suppressed because the altered receptor is active without needing extra aldosterone. This pattern helps distinguish Geller syndrome from primary aldosteronism, which usually has low renin but high aldosterone.
Why might spironolactone be unsafe for some people with Geller syndrome?
Spironolactone usually blocks the mineralocorticoid receptor, but the classic S810L mutation can make the drug activate the receptor instead. It may therefore worsen blood pressure or potassium loss in that specific setting, so medication decisions should be based on the exact genetic variant and specialist advice.
How is Geller syndrome diagnosed?
Doctors may look for early-onset high blood pressure with low potassium, then measure renin and aldosterone levels. Genetic testing can identify an NR3C2 variant such as S810L and help distinguish Geller syndrome from conditions such as primary aldosteronism, Liddle syndrome, and apparent mineralocorticoid excess.
What signs might suggest Geller syndrome rather than ordinary high blood pressure?
Clues include high blood pressure that begins early, low blood potassium, poor response to standard blood pressure medicines, or a marked worsening during pregnancy. These findings do not confirm Geller syndrome, but they can prompt hormone testing and genetic evaluation.

Get notified when new evidence is published on Hypertension due to gain-of-function mutations in the mineralocorticoid receptor.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    A Case Report of Recurrent Hypokalemia During Pregnancies Associated With Nonaldosterone-Mediated Renal Potassium Loss.

    Pintavorn P, Munie S

    Canadian journal of kidney health and disease 2021; (8()):20543581211017424 doi:10.1177/20543581211017424.

    PMID: 34104455
  2. 2

    Critical role of the mineralocorticoid receptor in aldosterone-dependent and aldosterone-independent regulation of ENaC in the distal nephron.

    Nesterov V, Bertog M, Canonica J, et al.

    American journal of physiology. Renal physiology 2021; (321(3)):F257-F268 doi:10.1152/ajprenal.00139.2021.

    PMID: 34251271
  3. 3

    The mineralocorticoid receptor (MR) regulates ENaC but not NCC in mice with random MR deletion.

    Czogalla J, Vohra T, Penton D, et al.

    Pflugers Archiv : European journal of physiology 2016; (468(5)):849-58 doi:10.1007/s00424-016-1798-5.

    PMID: 26898302
  4. 4

    [Regulation of kidney on potassium balance and its clinical significance].

    Xie QH, Hao CM

    Sheng li xue bao : [Acta physiologica Sinica] 2023; (75(2)):216-230.

    PMID: 37089096
  5. 5

    Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1.

    Amazit L, Le Billan F, Kolkhof P, et al.

    The Journal of biological chemistry 2015; (290(36)):21876-89 doi:10.1074/jbc.M115.657957.

    PMID: 26203193
  6. 6

    Progesterone: An enigmatic ligand for the mineralocorticoid receptor.

    Baker ME, Katsu Y

    Biochemical pharmacology 2020; (177()):113976 doi:10.1016/j.bcp.2020.113976.

    PMID: 32305433
  7. 7

    Structural determinants of activation of the mineralocorticoid receptor: an evolutionary perspective.

    Fuller PJ, Yao YZ, Yang J, Young MJ

    Journal of human hypertension 2021; (35(2)):110-116 doi:10.1038/s41371-020-0360-2.

    PMID: 32467588
  8. 8

    Clinical and Molecular Perspectives of Monogenic Hypertension.

    Levanovich PE, Diaczok A, Rossi NF

    Current hypertension reviews 2020; (16(2)):91-107 doi:10.2174/1573402115666190409115330.

    PMID: 30963979
  9. 9

    First European case of Geller syndrome complicated with hypokalemic nephropathy: A case report and literature review.

    Gavriilidis E, Antoniadou C, Dimopoulou G, et al.

    Metabolism open 2026; (29()):100429 doi:10.1016/j.metop.2025.100429.

    PMID: 41487602
  10. 10

    Refractory Hypokalemia of Pregnancy: A Rare Case of Non-Aldosterone Mediated Hypokalemia.

    Valiveti D, Lahey O, Nooruddin K, Addison B

    Cureus 2025; (17(2)):e79242 doi:10.7759/cureus.79242.

    PMID: 40115718
  11. 11

    The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

    Vaidya A, Mulatero P, Baudrand R, Adler GK

    Endocrine reviews 2018; (39(6)):1057-1088 doi:10.1210/er.2018-00139.

    PMID: 30124805
  12. 12

    Monogenic Kidney Disorders as Hidden Drivers of Electrolyte Imbalance and Hypertension.

    Ahn YH

    Electrolyte & blood pressure : E & BP 2026; (24(3)):147-157 doi:10.5049/EBP.2026.24.e15.

    PMID: 42812492
  13. 13

    Apparent mineralocorticoid excess mimicking Bartter syndrome in infancy.

    Hatipoğlu S, Yıldırım E, Şalbaş ÖY, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2026; doi:10.1515/jpem-2026-0333.

    PMID: 42912472

This page is for informational purposes only and does not replace medical advice. An endocrinologist, nephrologist, or genetics specialist should interpret your hormone tests and NR3C2 variant and guide medication decisions.